Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Belvedere

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Helvetica Paediatrica Acta|June 1, 1989
[Treatment of neuroblastoma. Results of therapy at the Zurich University Pediatric Clinic, 1967-1987]M Belvedere, H J Plüss
Rivista Di Emoterapia Ed Immunoematologia|January 1, 1977
[Italian "pre-workshop" for the study of B-lymphocyte membrane antigens]M Belvedere, P Diotallevi, P Richiardi
Journal of Immunogenetics|April 1, 1980
Xenoantisera to DRw allospecificitiesM Belvedere, M A Pellegrino, S Ferrone
Haematologica|February 1, 1980
[Xenoantisera against human B lymphocytes:possible detection of HLA-DR allospecificities (author's transl)]M Belvedere, P Richiardi, I Borelli, et al.
Journal of Immunogenetics|June 1, 1980
Fab2 fragments from HLA xenoantisera specifically block cytolysis mediated by HLA-AB alloantiseraM Belvedere, P Richiardi, M A Pellegrino, et al.
Haematologica|October 1, 1977
Evaluation of sensitive complement-dependent microcytotoxicity serological methodsP Richiardi, M Belvedere, I Borelli, et al.
Canadian Journal of Public Health = Revue Canadienne De Sante Publique|August 22, 2012
Shifting sands: changing regional and gender-specific patterns of HIV/AIDS mortality in Canada, 1987 to 2008Lindsay M Belvedere, Caroline L Miller, Robert S Hogg
Tissue Antigens|April 1, 1975
Antigenic determinants of the W28 molecule different from but spatially close to W28 determinantM Belvedere, P Richiardi, G Luciani, et al.
Haematologica|April 1, 1980
[Use of F (ab')2 blocking test for anti HLA antibody detection in xenoantisera]M Belvedere, P Richiardi, S Ferrone, et al.
Transplantation Proceedings|June 1, 1979
Reactivity of DR xenoantisera in a cytotoxic test with human complementM Belvedere, E Olivetti, M A Pellegrino, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Helvetica Paediatrica Acta|June 1, 1989
[Treatment of neuroblastoma. Results of therapy at the Zurich University Pediatric Clinic, 1967-1987]M Belvedere, H J Plüss
Rivista Di Emoterapia Ed Immunoematologia|January 1, 1977
[Italian "pre-workshop" for the study of B-lymphocyte membrane antigens]M Belvedere, P Diotallevi, P Richiardi
Journal of Immunogenetics|April 1, 1980
Xenoantisera to DRw allospecificitiesM Belvedere, M A Pellegrino, S Ferrone
Haematologica|February 1, 1980
[Xenoantisera against human B lymphocytes:possible detection of HLA-DR allospecificities (author's transl)]M Belvedere, P Richiardi, I Borelli, et al.
Journal of Immunogenetics|June 1, 1980
Fab2 fragments from HLA xenoantisera specifically block cytolysis mediated by HLA-AB alloantiseraM Belvedere, P Richiardi, M A Pellegrino, et al.
Haematologica|October 1, 1977
Evaluation of sensitive complement-dependent microcytotoxicity serological methodsP Richiardi, M Belvedere, I Borelli, et al.
Canadian Journal of Public Health = Revue Canadienne De Sante Publique|August 22, 2012
Shifting sands: changing regional and gender-specific patterns of HIV/AIDS mortality in Canada, 1987 to 2008Lindsay M Belvedere, Caroline L Miller, Robert S Hogg
Tissue Antigens|April 1, 1975
Antigenic determinants of the W28 molecule different from but spatially close to W28 determinantM Belvedere, P Richiardi, G Luciani, et al.
Haematologica|April 1, 1980
[Use of F (ab')2 blocking test for anti HLA antibody detection in xenoantisera]M Belvedere, P Richiardi, S Ferrone, et al.
Transplantation Proceedings|June 1, 1979
Reactivity of DR xenoantisera in a cytotoxic test with human complementM Belvedere, E Olivetti, M A Pellegrino, et al.
Pageof 5